Trademark: 88015911
Word
HEALIOS
Status
Registered
Status Code
700
Status Date
Tuesday, February 7, 2023
Serial Number
88015911
Registration Number
6970513
Registration Date
Tuesday, February 7, 2023
Mark Type
4000
Filing Date
Tuesday, June 26, 2018
Published for Opposition
Tuesday, November 22, 2022

Trademark Owner History
HEALIOS K.K. - Original Registrant

Classifications
5 Cells for medical or clinical use; cells for medical or clinical use for treatment of diseases; stem cells for medical purposes; stem cells for veterinary purposes; surgical implants comprising living tissue grown from stem cells; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological preparations for the treatment of ophthalmic, central nervous, respiratory, or cardiovascular disease; biological preparations for veterinary purposes for the treatment of cancer, liver disease and immune system related disease; diagnostic preparations for medical and veterinary use; diagnostic reagents for medicinal use; veterinary diagnostic reagents; adjuvants for medical purposes; cytostatics for medical purposes; pharmaceutical preparations for activating cellular function for the treatment of cancer, liver disease and immune system related disease; sanitary preparations for medical use; ophthalmic preparations; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for ocular or intraocular surgery; collyrium; eye drops; pharmaceutical agents affecting the central nervous system; pharmaceutical preparations for the peripheral nervous system; cardiovascular agents for medical purposes; cardiovascular treatment preparations; cardiovascular pharmaceuticals; cardiovascular pharmaceutical preparations; respiratory stimulants; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; anti-inflammatories; pharmaceutical agents affecting digestive organs; pharmaceutical agents for treating physically caused lesions; opotherapy preparations; organotherapy preparations; gene therapy products, namely, genetically engineered tissues for transplant purposes; surgical implants comprised of living tissues; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for use in the fields of anesthesia, oncology, urology and gynecology

Trademark Events
Feb 7, 2023
Notice Of Registration Confirmation Emailed
Feb 7, 2023
Registered-Principal Register
Nov 22, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 22, 2022
Published For Opposition
Nov 2, 2022
Notification Of Notice Of Publication E-Mailed
Oct 18, 2022
Electronic Record Review Complete
Oct 14, 2022
On Hold - Electronic Record Review Required
Oct 12, 2022
Case Returned To Examination
Oct 12, 2022
Notice Of Allowance Cancelled
Oct 7, 2022
Attorney Review/Decision On Amendment Required
Oct 7, 2022
Petition To Director - Change Basis - Granted
Oct 5, 2022
Assigned To Petition Staff
Sep 8, 2022
Teas Petition To Amend Basis Received
Mar 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 25, 2022
Sou Extension 4 Granted
Mar 25, 2022
Sou Extension 4 Filed
Mar 25, 2022
Teas Extension Received
Oct 16, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 14, 2021
Sou Extension 3 Granted
Oct 14, 2021
Sou Extension 3 Filed
Oct 14, 2021
Teas Extension Received
Mar 19, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 17, 2021
Sou Extension 2 Granted
Mar 17, 2021
Sou Extension 2 Filed
Mar 17, 2021
Teas Extension Received
Sep 10, 2020
Case Assigned To Intent To Use Paralegal
Aug 19, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 17, 2020
Sou Extension 1 Granted
Aug 17, 2020
Sou Extension 1 Filed
Aug 17, 2020
Teas Extension Received
May 12, 2020
Noa E-Mailed - Sou Required From Applicant
Mar 17, 2020
Official Gazette Publication Confirmation E-Mailed
Mar 17, 2020
Published For Opposition
Feb 26, 2020
Notification Of Notice Of Publication E-Mailed
Feb 13, 2020
Approved For Pub - Principal Register
Feb 12, 2020
Jurisdiction Restored To Examining Attorney
Nov 8, 2019
Notification Of Action Denying Req For Recon E-Mailed
Nov 8, 2019
Action Denying Req For Recon E-Mailed
Nov 8, 2019
Action Continuing Final - Completed
Oct 30, 2019
Teas/Email Correspondence Entered
Oct 30, 2019
Correspondence Received In Law Office
Oct 30, 2019
Assigned To Lie
Oct 23, 2019
Teas Request For Reconsideration Received
Oct 23, 2019
Ex Parte Appeal-Instituted
Oct 23, 2019
Jurisdiction Restored To Examining Attorney
Oct 23, 2019
Exparte Appeal Received At Ttab
Jul 17, 2019
Notification For Req For Recon Denied No Appeal Filed
Jul 17, 2019
Action For Req For Recon Denied No Appeal Filed E-Mailed
Jul 17, 2019
Action Req For Recon Denied No Appeal Filed Counted Not Mailed
Jul 1, 2019
Divisional Processing Complete
Apr 9, 2019
Divisional Request Received
Jul 1, 2019
Case Assigned To Intent To Use Paralegal
Apr 23, 2019
Notification Of Final Refusal Emailed
Apr 23, 2019
Final Refusal E-Mailed
Apr 23, 2019
Final Refusal Written
Apr 10, 2019
Teas/Email Correspondence Entered
Apr 9, 2019
Correspondence Received In Law Office
Apr 9, 2019
Teas Response To Office Action Received
Apr 9, 2019
Teas Request To Divide Received
Oct 16, 2018
Notification Of Non-Final Action E-Mailed
Oct 16, 2018
Non-Final Action E-Mailed
Oct 16, 2018
Non-Final Action Written
Oct 16, 2018
Assigned To Examiner
Jul 1, 2018
New Application Office Supplied Data Entered
Jun 29, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24